28228 Results for: "Biotium"

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 543)

Supplier: Biotium

Anti-IgG2a Goat Polyclonal Antibody (CF™ 647)

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 594)

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 680R)

Supplier: Biotium

This conjugate is prepared by labeling F(ab’)2 fragment of goat anti-mouse IgG (H+L) with CF™594 dye. CF™ dyes offer advantages in brightness, photostability, and specificity compared to other fluorescent dyes. Deep-red fluorescent CF™594 (Ex/Em 593/614 nm) is spectrally similar to Alexa Fluor® 594 and Texas Red® dye but yields much brighter protein conjugate, and has excellent photostability.

Alexa Fluor® and Texas Red® are registered trademarks of Thermo Fisher Scientific.

Supplier: Biotium

Anti-IgG Rabbit Polyclonal Antibody (CF™ 543)

Supplier: Biotium

Anti-IgG Chicken Polyclonal Antibody (CF™ 594)

Supplier: Biotium

Anti-IgG Goat Polyclonal Antibody (CF™ 543)

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 543)

Supplier: Biotium

Anti-IgG1 Goat Polyclonal Antibody (CF™ 350)

Supplier: Biotium

Anti-IgG Chicken Polyclonal Antibody (CF™ 633)

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 770)

Supplier: Biotium

Anti-IgG Goat Polyclonal Antibody (CF™ 543)

Supplier: Biotium

CF™640R antibodies are affinity-purified antibodies labeled with far-red fluorescent CF™640R, a member of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

Monoclonal mouse anti-biotin antibody reacts with biotin conjugated to antibodies or other proteins, and may show less non-specific binding to cells or tissues compared to streptavidin conjugates.

Supplier: Biotium

CF™543 antibodies are affinity-purified antibodies labeled with orange fluorescent CF™543 (Ex/Em 541/560nm), a member of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

CF™568 antibodies are affinity-purified antibodies labeled with red fluorescent CF™568, a member of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

CF™543 antibodies are affinity-purified antibodies labeled with orange fluorescent CF™543 (Ex/Em 541/560nm), a member of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

CF™350 is a blue fluorescent dye with excitation/emission maxima at 347/448nm. CF™350 is optimized for UV excitation, and is spectrally similar to AlexaFluor®350, AMCA, and DyLight®350. CF™350 is more water soluble, more photostable, and 50% brighter when conjugated to antibodies than the traditional blue dye AMCA. CF™350 antibody conjugates are comparable in brightness to AlexaFluor®350 dye conjugates.

Supplier: Biotium

CF™660C and CF™660R antibodies are affinity-purified antibodies labeled with far-red fluorescent CF™660C or CF™660R dyes, members of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

CF™660C and CF™660R antibodies are affinity-purified antibodies labeled with far-red fluorescent CF™660C or CF™660R dyes, members of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

CF™405 antibodies are affinity-purified antibodies labeled with blue fluorescent CF™405S or CF™405M, two members of the novel CF™ dye series developed by Biotium for labeling proteins and other biomolecules. CF™ dyes are designed to offer advantages in brightness, photostability, and/or specificity compared to other commercial dyes, and are available in colors spanning the visible, far-red, and near-infrared spectra.

Supplier: Biotium

Anti-IgG Goat Polyclonal Antibody (CF™ 568)

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 555)

Supplier: Biotium

CF™ dyes are superior to other fluorescent dyes for protein labelling due to advantages in brightness, photostability and water solubility.

Supplier: Biotium

Anti-IgG Donkey Polyclonal Antibody (CF™ 594)

Supplier: Biotium

NucView® 488 caspase-3 substrate is a novel cell membrane-permeable fluorogenic caspase substrate designed for detecting caspase-3 activity within live cells in real time.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ring-like, perinuclear from ductal peripheral-predominant carcinoma of the breast.

Supplier: Biotium

This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40 kDa. Its epitope maps between amino acid 312-335. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

Supplier: Biotium

Chromogranin A is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheochromocytomas, paragangliomas, and other neuroendocrine tumors. Co-expression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms. Reportedly, co-expression of certain keratins and chromogranin indicates neuroendocrine lineage. The presence of strong anti-chromogranin staining and absence of anti-keratin staining should raise the possibility of paraganglioma. The co-expression of chromogranin and NSE is typical of neuroendocrine neoplasms. Most pituitary adenomas and prolactinomas readily express chromogranin.